Mittie Doyle - 31 Mar 2022 Form 4 Insider Report for DICE Therapeutics, Inc.

Role
Director
Signature
/s/ Scott Robertson as attorney-in-fact for Mittie Doyle
Issuer symbol
N/A
Transactions as of
31 Mar 2022
Net transactions value
$0
Form type
4
Filing time
01 Apr 2022, 18:27:04 UTC
Previous filing
01 Apr 2022
Next filing
09 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DICE Stock Option (right to buy) Award $0 +42,500 $0.000000 42,500 31 Mar 2022 Common Stock 42,500 $19.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/36th of the total shares on each monthly anniversary of March 31, 2022, subject to the Reporting Holder's continued service to the Registrant.